This report contains market size and forecasts of Targeted Drugs for NSCLC in Global, including the following market information:
Global Targeted Drugs for NSCLC Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Targeted Drugs for NSCLC market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Target EGFR Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Targeted Drugs for NSCLC include Allergan, Amgen, ARIAD Pharmaceuticals (Takeda), Beacon Pharma Limited, BeiGene, Biocon, Boehringer-Ingelheim, Celgene Corporation and Drug International Limted, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Targeted Drugs for NSCLC companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Targeted Drugs for NSCLC Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Targeted Drugs for NSCLC Market Segment Percentages, by Type, 2021 (%)
Target EGFR
Target ALK
Target HER2
Target ROS1
Target BRAF
Target MEK
Target VEGFR2
Target VEGF
Target MET
Global Targeted Drugs for NSCLC Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Targeted Drugs for NSCLC Market Segment Percentages, by Application, 2021 (%)
Squamous Cell Carcinoma of NSCLC
Adenocarcinoma of NSCLC
Large Cell Carcinoma of NSCLC
Global Targeted Drugs for NSCLC Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Targeted Drugs for NSCLC Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Targeted Drugs for NSCLC revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Targeted Drugs for NSCLC revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Allergan
Amgen
ARIAD Pharmaceuticals (Takeda)
Beacon Pharma Limited
BeiGene
Biocon
Boehringer-Ingelheim
Celgene Corporation
Drug International Limted
Fujifilm Kyowa Kirin Biologics
Genvio Pharma Limited
Hetero Drugs
ImClone Systems ‎(Eli Lilly)
Incepta Pharmaceuticals
Mylan
Novartis
Pfizer
Reliance Lifesciences
Roche
AstraZeneca
Cipla
Teva
OSI Pharmaceuticals
Glenmark Pharmaceuticals
Natco Pharma